Manufacturer
AbbVie Inc.
13 drugs, 52 product strengths, 16 recalls on record.
Drugs AbbVie Inc. makes
SynthroidNo changeBrand · levothyroxinePharmacies pay from$49.691 open recallHumiraNo changeBrand · adalimumabPharmacies pay from$6,732Skyrizi-0.1%Brand · risankizumabNo weekly priceRinvoq+0.1%Brand · upadacitinibPharmacies pay from$6,881Depakote-0.1%Brand · valproatePharmacies pay from$58.96UnavailableCreonNo changeBrand · amylase / lipase / proteasePharmacies pay from$53.30LupronNo changeBrand · leuprolidePharmacies pay from$1,821Being discontinuedQuliptaNo changeBrand · atogepantPharmacies pay from$1,150OrilissaNo changeBrand · elagolixPharmacies pay from$658Elagolix / estradiol / norethindrone-0.2%Generic · 1 makerPharmacies pay from$308GengrafNo changeBrand · cyclosporinePharmacies pay from$55.96Mavyret-0.1%Brand · glecaprevir / pibrentasvirPharmacies pay from$4,587NorvirNo changeBrand · ritonavirPharmacies pay from$250Being discontinued
Recalls
Class IIIOngoingJun 3, 2026PRED MILDFailed Stability SpecificationsAbbVie Inc. · D-0551-2026Class IIOngoingOct 2, 2024Refresh P.MLack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.AbbVie Inc. · D-0664-2024Class IIOngoingOct 2, 2024Refresh LACRI-LUBELack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.AbbVie Inc. · D-0665-2024Class IIIOngoingNov 15, 2023SynthroidLabeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg...AbbVie Inc. · D-0088-2024Class IIITerminatedFeb 7, 2018Ultane (sevoflurane)Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.AbbVie Inc. · D-0412-2018Class IIITerminatedNov 1, 2017AndroGelTemperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.AbbVie Inc. · D-0033-2018Class IIITerminatedNov 1, 2017AndroGelTemperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.AbbVie Inc. · D-0034-2018Class IITerminatedMar 8, 2017Duopa (carbidopa and levodopa enteral suspension)Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within...AbbVie Inc. · D-0495-2017Class IIITerminatedApr 27, 2016ZemplarFailed Content Uniformity SpecificationsAbbVie Inc. · D-0833-2016Class IITerminatedOct 8, 2014CREON (pancrelipase) Delayed-Release CapsulesPresence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.AbbVie Inc · D-1611-2014Class IITerminatedMay 7, 2014Lupron DepotDefective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.AbbVie Inc · D-1287-2014Class IITerminatedMay 7, 2014Lupron DepotDefective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.AbbVie Inc · D-1288-2014Class IITerminatedMay 7, 2014LUPRON DEPOT-PEDDefective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.AbbVie Inc · D-1289-2014Class IITerminatedMay 7, 2014Lupron DepotDefective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.AbbVie Inc · D-1290-2014Class IITerminatedMay 7, 2014Lupron DepotDefective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.AbbVie Inc · D-1291-2014Class IIITerminatedAug 28, 2013Mavik¿ trandolapril tablets 4mgLabeling: Incorrect Package Insert; product packaged with outdated version of the insertAbbVie Inc. · D-901-2013
About AbbVie Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.